FDA Drug Recalls

Recalls / Class II

Class IID-1497-2019

Product

GENCONTUSS (Chlorpheniramine Maleate, 2mg; Dextromethorphan HBr, 10 mg; Phenylephrine HCl, 5 mg) in each 5 mL tsp, Cherry Flavor, 16 fl oz (474 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-650-16.

Brand name
Gencontuss
Generic name
Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Active ingredients
Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Route
Oral
NDC
52083-650
FDA application
M012
Affected lot / code info
All lots remaining within expiry.

Why it was recalled

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Recalling firm

Firm
Pharma-Natural Inc.
Manufacturer
KRAMER NOVIS
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
14500 Nw 60th Ave Bldg 7f, N/A, Miami Lakes, Florida 33014

Distribution

Quantity
3000 bottles
Distribution pattern
Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.

Timeline

Recall initiated
2019-06-21
FDA classified
2019-07-23
Posted by FDA
2019-07-31
Terminated
2021-10-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1497-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.